Leslie L. Iversen is Director at ACADIA PHARMACEUTICALS INC (ACAD). They have made 2 open-market trades across 1 company since 2009, most recently 2016-04-18.
CIK 0001291623
1 open-market purchase totalling $5K since 2009, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACAD | 36,127 | $691K |
Shares reported on the most recent Form 4, priced at the 2016-04-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACAD | SELL | 2016-04-18 | 2016-04-20 | $33.53 | $2.3M | -1.0% | +2.1% | -1.8% |
| ACAD | SELL · 10b5-1 | 2015-11-11 | 2015-11-13 | $36.01 | $1.1M | -33.1% | +0.1% | -49.2% |
| ACAD | SELL · 10b5-1 | 2014-01-02 | 2014-01-03 | $25.03 | $1.5M | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-09-12 | 2013-09-13 | $22.92 | $1.4M | -33.1% | +0.1% | +0.1% |
| ACAD | BUY | 2009-05-18 | 2009-05-20 | $1.65 | $5K | -33.1% | +0.1% | +0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.